Rybrevant Faspro J Code: J9062

Drug & Product Overview

HCPCS Descriptor Injection, amivantamab 5 mg and hyaluronidase-lpuj

HCPCS Added Date July 1, 2026

Manufacturer Janssen

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection

About Rybrevant Faspro

Rybrevant Faspro is a medication aligned to the HCPCS J Code: J9062 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the subcutaneous route and manufactured by Janssen.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
57894-0510-01	Rybrevant Faspro	Janssen Biotech, Inc.	320	1600 MG / 10 ML
57894-0514-01	Rybrevant Faspro	Janssen Biotech, Inc.	448	2240 MG / 14 ML
57894-0515-01	Rybrevant Faspro	Janssen Biotech, Inc.	480	2400 MG / 15 ML
57894-0522-01	Rybrevant Faspro	Janssen Biotech, Inc.	704	3520 MG / 22 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Rybrevant Faspro Pricing & Reimbursement

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

Rybrevant Faspro CPT Administration Codes

CPT Code	Description
96401	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Rybrevant Faspro Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 19 deletions or exon 21 L858R substitution mutations Locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations

Drug Class

Endoglycosidase [EPC]Glycoside Hydrolases [CS]

Frequently Asked Questions

Is there an available Rybrevant Faspro billing and coding guide?

Billing and coding information for Rybrevant Faspro can be found through Janssen. Visit Here →

Are there any available Rybrevant Faspro patient assistance programs?

RYBREVANT FASPRO patient assistance information can be found through JANSSEN BIOTECH. Visit Here →

Where can I find Rybrevant Faspro prescribing information?

RYBREVANT FASPRO prescribing information can be found at the link below: Visit Here →

Where can I find Rybrevant Faspro side effect information?

No RYBREVANT FASPRO side effect information link was found.

Does billing RYBREVANT FASPRO require JZ/JW wastage modifiers?

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.